Olivia Newton-John Cancer Wellness & Research Centre

Recent papers from Olivia Newton-John Cancer Wellness & Research Centre

1. Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironmentMolecular Cancer Therapeutics · 2026
2. The Evolving Landscape of Stage III Endometrial Cancer—A Narrative Review of Management in AustraliaJournal of Medical Imaging and Radiation Oncology · 2026
3. Nanoagonist‐mediated spatiotemporal reprogramming of macrophage phenotypes to potentiate tumor immunotherapyBMEMat · 2026
4. Outcomes and tolerability of bendamustine dose reductions when used in combination with anti-CD20 antibody as initial therapy in elderly patients with indolent lymphoproliferative disordersLeukemia & lymphoma/Leukemia and lymphoma · 2026
5. Tumour Antigen‐Specific Antibody Signatures as Diagnostic Biomarkers for MelanomaInternational Journal of Cancer · 2026
6. Prospective phase I study of nivolumab to promote graft‐versus‐tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantationBritish Journal of Haematology · 2026
7. Divergent genomic evolution in astrocytomas and oligodendrogliomasNature · 2026
8. An Exploratory Study of ABT-806, a Tumor-Specific Anti-EGFR Antibody, in Subjects with Recurrent or Metastatic Head and Neck and Other Squamous Cell CarcinomasCancers · 2026
9. Electronic patient-reported outcome platforms used in hematological cancers: a systematic reviewSupportive Care in Cancer · 2026
10. A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivoScience Advances · 2026
11. StrataXRT Versus Mepitel Film for Prevention of Acute Radiation Dermatitis in Postmastectomy Radiotherapy: A Pooled Analysis of Intra‐Patient Randomised TrialsJournal of Medical Radiation Sciences · 2026
12. ASO Author Reflections: Multi-Modal Prehabilitation and Outcomes After Gastroesophageal Cancer Surgery: A Cohort Study of Pulmonary Complications and Resilience to Major Postoperative EventsAnnals of Surgical Oncology · 2026
13. Appearance of Stabilised Hyaluronic Acid Gel on Routine Surveillance Breast Imaging When Used to Mark the Post‐Lumpectomy Tumour Bed in Breast CancerJournal of Medical Imaging and Radiation Oncology · 2026
14. Coordination of care in the context of primary brain tumors: Australian healthcare professionals’ exploration of the unspoken impact and clinical implicationsSupportive Care in Cancer · 2026
15. LTB ‐ TREAT : A validated international prognostic model for time to treatment in low tumour burden follicular lymphomaBritish Journal of Haematology · 2026
16. Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in AustraliaAsia-Pacific Journal of Clinical Oncology · 2026
17. From data silos to integrated diagnosis: multimodal machine learning in glioblastomaFrontiers in Oncology · 2026
18. Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F networkEMBO Molecular Medicine · 2026
19. Novel chimeric PD-L1::PD-L2 fusion and immune evasion in lymphomanpj Precision Oncology · 2026
20. Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R‐ CHOP : A Lymphoma Registry StudyEuropean Journal Of Haematology · 2026